LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

19.39 5.9

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

18.34

Max

19.93

Pagrindiniai rodikliai
By Trading Economics
Pajamos	2M -17M
Pardavimai	178K 264K
Pelnas, tenkantis vienai akcijai	-0.257
Pelno marža	-6,603.409
Darbuotojai	116
EBITDA	2M -17M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+64.29% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	13.49
Ankstesnė uždarymo kaina	19.39

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-10 20:38; UTC

Uždarbis

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

2026-03-10 23:57; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-10 23:57; UTC

Rinkos pokalbiai

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

2026-03-10 23:47; UTC

Rinkos pokalbiai

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

2026-03-10 23:37; UTC

Įsigijimai, susijungimai, perėmimai

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

2026-03-10 23:37; UTC

Įsigijimai, susijungimai, perėmimai

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

2026-03-10 23:37; UTC

Įsigijimai, susijungimai, perėmimai

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

2026-03-10 23:37; UTC

Įsigijimai, susijungimai, perėmimai

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

2026-03-10 23:35; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

2026-03-10 23:06; UTC

Uždarbis

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

2026-03-10 22:51; UTC

Svarbiausios naujienos

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

2026-03-10 21:39; UTC

Įsigijimai, susijungimai, perėmimai

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

2026-03-10 21:21; UTC

Uždarbis

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

2026-03-10 21:15; UTC

Uždarbis

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

2026-03-10 21:15; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

2026-03-10 21:14; UTC

Uždarbis

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

2026-03-10 21:13; UTC

Uždarbis

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

2026-03-10 21:12; UTC

Uždarbis

Franco-Nevada 4Q Rev $597.3M >FNV

2026-03-10 21:12; UTC

Uždarbis

Franco-Nevada 4Q EPS $1.90

2026-03-10 20:57; UTC

Uždarbis

Oracle Stock Jumps on Earnings Beat -- Barrons.com

2026-03-10 20:50; UTC

Rinkos pokalbiai

Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2026-03-10 20:44; UTC

Uždarbis

Oracle Stock Jumps on Earnings Beat -- Barrons.com

2026-03-10 20:34; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2026-03-10 20:34; UTC

Rinkos pokalbiai

Uždarbis

Oracle Building More Software for Less Money After Restructuring -- Market Talk

2026-03-10 20:23; UTC

Uždarbis

Oracle Stock Jumps on Earnings Beat -- Barrons.com

2026-03-10 20:16; UTC

Uždarbis

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

2026-03-10 20:14; UTC

Uždarbis

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

2026-03-10 20:14; UTC

Uždarbis

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

2026-03-10 20:13; UTC

Uždarbis

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

2026-03-10 20:12; UTC

Uždarbis

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

64.29% į viršų

12 mėnesių prognozė

Vidutinis 30 USD 64.29%

Aukščiausias 30 USD

Žemiausias 30 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.